Home  /  Resource Library  /  Front-Line Treatment with Obinutuzumab ± Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice

Front-Line Treatment with Obinutuzumab ± Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice

ASH 2019: Retrospective study investigated the effectiveness of Obinutuzumab combined with Chlorambucil for first line treatment of CLL in the real world setting.